Procore is a clinical stage regenerative medicine company committed to developing innovative, cost effective solutions with a focus on bone and cartilage regeneration, integrating proprietary hydrogels, growth factors, stem and progenitor cells.
The company technology platform includes:
- Biomaterials and in particular Hyaluronic Acid (HA) and fibrinogen based hydrogels useful for multiple clinical applications.
- Proprietary growth factors with enhanced selectivity and biological activity.
- Unique and innovative protocols for stem and progenitor cell isolation, expansion and differentiation.
ProCore Bio Med Ltd. is a member of two consortiums in the prestigious EU 7th Framework Programme for Research & Technological Development.
ProCore owns a cell therapy facility with cGMP, ISO 9001 and ISO13485:2003 accrediation and a proven track record in producing clinical grade products.